Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study

• Ahmad Shahin, BS,
• Monica Janeczek, MD,
• Richard Butterfield, MA,
• Puneet Bhullar, BS,
• Blake Boudreaux, MD,
• Thai Ho, MD, PhD,
• Aaron Mangold, MD

Affiliations

Ahmad Shahin, BS

Mayo Clinic Alix School of Medicine, Scottsdale, Arizona

Monica Janeczek, MD

Department of Dermatology, Mayo Clinic, Scottsdale, Arizona

Richard Butterfield, MA

Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona

Puneet Bhullar, BS

Mayo Clinic Alix School of Medicine, Scottsdale, Arizona; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona

Blake Boudreaux, MD

Department of Dermatology, Mayo Clinic, Scottsdale, Arizona

Thai Ho, MD, PhD

Division of Medical Oncology, Mayo Clinic, Phoenix, Arizona

Aaron Mangold, MD

Department of Dermatology, Mayo Clinic, Scottsdale, Arizona; Correspondence to: Aaron Mangold, MD, Mayo Clinic Arizona, 13400 E Shea Boulevard, Scottsdale, AZ 85259